Pre-Course Offerings


Hotel                 Register Now

Expand Your Clinical Knowledge

Take advantage of two valuable pre-courses that will qualify you for a DEA waiver for prescribing buprenorphine and educate you on the safe prescribing of Extended Release/Long Acting Opioids. These courses are held just prior to the ASAM Review Course in Addiction Medicine on Wednesday, July 26, 2017. 


  1. Attendance at the Review Course is not required to partake in these two offerings.
  2. Registration for these two pre-course offerings is NOT included in Review Course registration.
  3. Review Course attendees are welcome to attend but do not need to attend these courses as part of the Certification Examination preparation.


The ASAM Treatment of Opioid Use Disorder Course - Includes Waiver Qualifying Requirements - $199

Wednesday, July 26, 2017
1:00 pm - 5:30 pm 

The ASAM Treatment of Opioid use Disorder Course provides the required 8 hours needed to obtain the waiver to prescribe buprenorphine in office-based treatment of opioid use disorders and reviews other medications as well.  ASAM offers this 8-hour course in a blended format combining online and live learning. The first half of the course is administered online through 4 hours of independent self-paced learning. The second half of the course is delivered by recognized national experts in a 4-hour interactive and engaging face-to-face classroom setting. 


The CO*RE/ASAM Opioid Prescribing: Safe Practice, Changing LivesFree!

Wednesday, July 26, 2017
6:30 pm - 9:00 pm
Nationwide Via LIVE Webinar

This safe use of Extended Release/Long Acting Opioids course was developed by nationally recognized experts in the ER/LA opioid field. ASAM’s course also includes a special section on addiction medicine. Participants, live and remote, must complete the course assessment and evaluation to claim credit.